
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
Baltimore - PUVA and phototherapy are safe and effective for the treatment of more than two dozen conditions, but of the dermatologists who provide these treatments, as many as half use them solely for psoriasis, according to Warwick L. Morison M.D., professor of dermatology, Johns Hopkins Medical School, Baltimore.